Show simple item record

dc.contributor.authorMancini, A
dc.contributor.authorChelini, A
dc.contributor.authorDi Capua, A
dc.contributor.authorCastelli, L
dc.contributor.authorBrogi, S
dc.contributor.authorPaolino, M
dc.contributor.authorGiuliani, G
dc.contributor.authorCappelli, A
dc.contributor.authorFrosini, M
dc.contributor.authorRicci, L
dc.contributor.authorLeonelli, E
dc.contributor.authorGiorgi, G
dc.contributor.authorGiordani, A
dc.contributor.authorMagistretti, J
dc.contributor.authorAnzini, M
dc.date.accessioned2017-07-25T12:30:30Z
dc.date.available2017-07-25T12:30:30Z
dc.date.issued2017
dc.identifier.issn0223-5234
dc.identifier.doi10.1016/j.ejmech.2016.11.053
dc.identifier.urihttp://hdl.handle.net/10072/342181
dc.description.abstractNeurodegenerative diseases are disorders related to the degeneration of central neurons that gradually lead to various, severe alterations of cognitive and/or motor functions. Currently, for no such diseases does any pharmacological treatment exist able to arrest its progression. Riluzole (1) is a small molecule able to interfere with multiple cellular and molecular mechanisms of neurodegeneration, and is the only approved treatment of amyotrophic lateral sclerosis (ALS), the progression of which proved to significantly slow, thus increasing somewhat average survival. Here we report the synthesis of differently functionalized 4H-3,1-benzothiazine (5–6) and 2H-1,4-benzothiazine (7) series as superior homologues of 1. Biological evaluation demonstrated that amidine 4H-3,1-benzothiazine derivatives 5b-d can reduce glutamate and LDH release in the oxygen/glucose deprivation and reperfusion model (OGD/R) applied to brain slices with a higher potency than 1. Moreover the mentioned compounds significantly reduce glutamate- and 6-hydroxydopamine (6-OHDA)-induced cytotoxicity in neuroblastoma cells. In addition, the same compounds limit ROS formation in both neuronal preparations. Finally, 5c proved effective in inhibiting neuronal voltage-dependent Na+ and Ca2+-channels, showing a profile comparable with that of 1.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofpagefrom614
dc.relation.ispartofpageto630
dc.relation.ispartofjournalEuropean Journal of Medicinal Chemistry
dc.relation.ispartofvolume126
dc.subject.fieldofresearchMedicinal and Biomolecular Chemistry not elsewhere classified
dc.subject.fieldofresearchMedicinal and Biomolecular Chemistry
dc.subject.fieldofresearchOrganic Chemistry
dc.subject.fieldofresearchPharmacology and Pharmaceutical Sciences
dc.subject.fieldofresearchcode030499
dc.subject.fieldofresearchcode0304
dc.subject.fieldofresearchcode0305
dc.subject.fieldofresearchcode1115
dc.titleSynthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.hasfulltextNo Full Text
gro.griffith.authorDi Capua, Angela


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record